Available Forms: Lyophilized powder for injection
Available Strengths: 500 mg/vial, 2 g/vial
Reference Brands: Desferal
Category: Anemia
Deferoxamine (Desferal) treats acute and chronic iron overload. Available in 500 mg and 2 g vials. Trusted for B2B pharma supply globally.
Quick Response Guaranteed | Verified Suppliers
Product Description:
Deferoxamine (Desferal®) is a trusted parenteral iron chelator used in the treatment of acute iron poisoning and chronic iron overload due to frequent blood transfusions, especially in thalassemia and sickle cell disease. Available as 500 mg and 2 g lyophilized powder for injection, it is administered via IV, IM, or subcutaneous infusion. Marketed under the brand Desferal in the US and EU, it’s manufactured under GMP-compliant standards for hospital and clinical use. Ideal for global B2B pharmaceutical procurement. Contact us for bulk export, COAs, and regulatory support documents.
Deferoxamine is used to treat chronic iron overload caused by repeated blood transfusions, commonly seen in conditions like thalassemia, sickle cell disease, and certain anemias. It is also used for acute iron poisoning. It works by binding excess iron and helping the body eliminate it.
Deferoxamine is made from the active compound deferoxamine mesylate, a chelating agent that binds free iron and forms a stable complex that can be excreted from the body.
Deferoxamine is marketed under trade names such as Desferal and other region-specific brands.
Major manufacturers include Novartis (producer of Desferal) and several licensed pharmaceutical companies in different regions who produce generic formulations.
The generic name of the product is deferoxamine mesylate.
It is available under brand names such as Desferal, with additional region-specific branded generics depending on the market.
Deferoxamine is manufactured in multiple countries including Switzerland, the United States, and India, depending on the pharmaceutical company producing it. The exact manufacturing location varies by manufacturer.
Strength: 150 mg, 300 mg
Form: Tablets
Reference Brands: Vafseo (EU/EU/UK)
Strength: 5 mg, 20 mg, 50 mg
Reference Brands: Pyrukynd (USA)
Strength: 12.5 mg, 25 mg, 50 mg, and 75 mg
Form: Tablets / Oral suspension
Reference Brands: Promacta (USA), Revolade (EU)
Strength: 1,000 IU, 2,000 IU, 4,000 IU, 10,000 IU, 40,000 IU
Form: injection (prefilled syringe)
Reference Brands: EPOGEN (USA), PROCRIT (USA)
By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under βFair use.β
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Stay updated on pharma trends and marketplace opportunities.
Online Β· B2B Pharma Β· Medical Tourism Β· NPP